HK

Hari Kishan Yadav

Active Director Director DIN 09110034
DIN 09110034 First appointment Mar 2021 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Hari Kishan Yadav

Data last updated:

Hari Kishan Yadav is a Director at Hvc Pharma Private Limited (since 2021). The company operates in Trading. Hvc Pharma Private Limited reported revenue of ₹18.8 Lakh (FY 2025).

DIN 09110034
Primary Designation Director
Industry Trading
First Appointment 17 Mar 2021
Oldest Company Age 5 yrs
Largest company Hvc Pharma Private Limited · ₹18.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hvc Pharma Private Limited U51909MH2021PTC357183
Director17 Mar 20212021₹18.8 Lakh (FY 2025)Active

Board colleagues of Hari Kishan Yadav

Directorship timeline

Open interactive timeline →
Hvc Pharma Private Limited
Premium access

Shareholding and investment profile for Hari Kishan Yadav

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hari Kishan Yadav

Hari Kishan Yadav currently holds 1 directorship: Hvc Pharma Private Limited (Director, since 17 Mar 2021, revenue ₹18.8 Lakh (FY 2025)).

Hari Kishan Yadav was first appointed on 17 Mar 2021 as Director at Hvc Pharma Private Limited.

The current boards of Hari Kishan Yadav's companies include Chandan Singh Yadav (Hvc Pharma Private Limited), Vinod Kumar Yadav (Hvc Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available